Literature DB >> 5016922

Revascularization of both cardiac ventricles by right ventricular implants.

A M Vineberg, M M Lwin.   

Abstract

Implantation of the right internal mammary artery into the wall of the right ventricle has been performed in 48 patients whose cases have been followed up for longer than six months. The procedure was done at the same time as a left ventricular implantation or subsequent to this operation because of recurrence or persistence of symptoms. Relief of anginal pain has been achieved in 78% and of chronic left ventricular failure in 75%. Of the 40 patients who had already had one or more myocardial infarctions preoperatively, 36 are still alive, with an average survival of over 5 years.

Entities:  

Mesh:

Year:  1972        PMID: 5016922      PMCID: PMC1940534     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  Surgical treatment of coronary heart disease.

Authors:  W G Bigelow
Journal:  Can Med Assoc J       Date:  1971-03-20       Impact factor: 8.262

2.  Selection of patients and operation for revascularization surgery.

Authors:  A Vineberg; J Shanks
Journal:  JAMA       Date:  1969-01-20       Impact factor: 56.272

3.  The continuity of right and left ventricular myocardial sinusoidal spaces and its relation to right ventricular implants.

Authors:  A Vineberg; A K Syed
Journal:  Can Med Assoc J       Date:  1970-04-25       Impact factor: 8.262

4.  The rationale of revascularization surgery.

Authors:  A Vineberg
Journal:  Dis Chest       Date:  1969-03

5.  Right internal mammary artery implantation into right ventricular myocardium for revascularization of the entire heart: experimental data and preliminary report.

Authors:  A M Vineberg; B O Zamora
Journal:  Can Med Assoc J       Date:  1966-09-10       Impact factor: 8.262

  5 in total
  1 in total

1.  Average duration of life.

Authors:  A C Irwin
Journal:  Can Med Assoc J       Date:  1972-06-24       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.